The inhibition of either PI3K or AKT led to an increase in the population of effector CD8+ T cells with upregulation of activation marker, elevated CD39CD69 memory T cells, and significantly enhanced cytotoxicity when cocultured with tumor cell lines and patient‐derived tumor samples. This evidence concerns the gene CD8A and neoplasm.